Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging

Annals of Neurology

Volumn 47, Issue 1, 2000, Pages 93-100

  Alsop, David C ^a   Detre, John A ^a   Grossman, Murray ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD OXYGENATION; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DEMENTIA; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; RIGHT HANDEDNESS; STATISTICAL ANALYSIS; STROKE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 0033976957     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8     Document Type: Article

References (47)

1. Frackowiak RSJ, Pozzilli C, Legg NJ, et al. Regional cerebral oxygen supply and utilization in dementia. Brain 1981;104: 753-778
2. Haxby JV, Grady CL, Duara R, et al. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Arch Neurol 1986;43:882-885
3. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease. Lancet 1994;344:895
4. Jagust WJ. Functional imaging patterns in Alzheimer's disease. Ann NY Acad Sci 1996;777:30-36
5. Waldemar G. Functional brain imaging with SPECT in normal aging and dementia. Cerebrovasc Brain Metab Rev 1995;7: 89-130
6. Bartenstein P, Minoshima S, Hirsch C, et al. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. J Nucl Med 1997;38:1095-1101
7. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996;334:752-758
8. Kennedy AM, Frackowiak RSJ, Newman SK, et al. Deficits in cerebral glucose-metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 1995;186:17-20
9. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility contrast. Magn Reson Med 1990;14: 538-546
10. Ogawa S, Tank DW, Menon R, et al. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci USA 1992;89:5951-5955
11. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23:37-45
12. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging ot perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 1992;89:212-216
13. Ostergaard L, Weisskoff RM, Chesler DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725
14. Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996;199:391-401
15. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood-volume maps of gliomas: comparison with tumor grade and histologic-findings. Radiology 1994;191:41-51
16. Gonzalez RG, Fischman AJ, Guimaraes AR, et al. Functional MR in the evaluation of dementia: correlation ot abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fluorodeoxyglucose. AJNR Am J Neuroradiol 1995;16:1763-1770
17. Harris GJ, Lewis RF, Satlin A, et al. Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease. Am J Psychiatry 1996;153:721-724
18. Roberts DA, Detre JA, Bolinger L, et al. Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water. Proc Natl Acad Sci USA 1994;91:33-37
19. Edelman RR, Siewert B, Darby DG, et al. Qualitative mapping of cerebral blood flow and functional localization with echoplanar MR imaging and signal targeting with alternating radio frequency. Radiology 1994;192:513-520
20. Sandson TA, O'Connor M, Sperling RA, et al. Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report. Neurology 1996;47:1339-1342
21. Alsop DC, Detre JA. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998; 208:410-416
22. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236-1249
23. McKhann G, Drachmann D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report on the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944
24. Grossman M, Desposito M, Hughes E, et al. Language comprehension profiles in Alzheimer's disease multi-infarct dementia, and frontotemporal degeneration. Neurology 1996;47: 183-189
25. Folstein MF, Folstein SF, McHugh PR. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
26. Detre JA, Alsop DC, Vives LR, et al. Noninvasive MRI evaluation ot cerebral blood flow in cerebrovascular disease. Neurology 1998;50:633-641
27. Alsop DC. Correction of ghost artifacts and distortion in echoplanar MR imaging with an iterative image reconstruction technique. Radiology 1995;197P:388 (Abstract)
28. Alsop DC, Detre JA. Reduction of excess noise in fMRI using noise image templates. In: Proceedings of the International Society for Magnetic Resonance in Medicine Fifth scientific meeting and exhibition. Berkeley, CA: International Society tor Magnetic Resonance in Medicine, 1997:1687 (Abstract)
29. Maccotta L, Detre JA, Alsop DC. The efficiency of adiabatic inversion for perfusion imaging by arterial spin labeling. NMR Biomed 1997;10:216-221
30. Friston KJ, Ashburner J, Frith CD, et al. Spatial registration and normalization of images. Hum Brain Mapp 1995;2:165-189
31. Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 1991;11:690-699
32. Burdette JH, Minoshima S, Borght TV, et al. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 1996;198:837-843
33. Hanaway J, Woolsey TA, Gado MH, Roberts MP. The brain atlas: a visual guide to the central nervous system. Bethesda: Fitzgerald Science Press, 1998
34. Gur RC, Gur RE, Obrist WD, et al. Age and regional cerebral blood flow at rest and during cognitive activity. Arch Gen Psychiatry 1987;44:617-621
35. Martin AJ, Friston KJ, Colebatch JG, Frackowiak RSJ. Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab 1991;11:684-689
36. Messa C, Perani D, Lucignam G, et al. High resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET. J Nucl Med 1993;35:210-216
37. Nagata K, Buchan RJ, Yokoyama E, et al. Misery perfusion with preserved vascular reactivity in Alzheimer's disease. Ann NY Acad Sci 1997;826:271-281
38. Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer's disease using 3-dimensional stereotaxic surface projections of fluorine-18-Fdg Pet. J Nucl Med 1995;36:1238-1248
39. Alavi A, Newberg AB, Souder E, Berlin JA. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 1993;1993:1681-1687
40. Meltzer CC, Zubieta JK, Brandt J, et al. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 1996;47:454-461
41. Gijn JV. Leukoaraiosis and vascular dementia. Neurology 1998; 51:S3-S8
42. Buee L, Hof PR, Bouras C, et al. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (Berl) 1994;87:469-480
43. Hachinski V, Munoz DG. Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon. Ann NY Acad Sci 1997;826:1-6
44. Silva A, Zhang W, Williams D, Koretsky A. Estimation of water extraction fractions in rat brain using magnetic resonance measurement of perfusion with arterial spin labeling. Magn Reson Med 1997;37:58-68
45. Jagust WJ, Eberling JL, Richardson BC, et al. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease. Brain Res 1993;629:189-198
46. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259
47. Alsop DC, Detre JA. Background suppressed 3D RARE arterial spin labeled perfusion MRI. In: Proceedings of the International Society for Magnetic Resonance in Medicine Seventh scientific meeting and exhibition. Berkeley, CA: International Society for Magnetic Resonance in Medicine, 1999 (Abstract)